Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2940 E Banner Gateway Dr
Gilbert, AZ 85234Phone+1 480-256-5133
Summary
- Dr. Devin N Patel is an urologic oncologist in Arizona and is affiliated with Banner MD Anderson Cancer Center. He received his medical degree from The George Washington University and has been in practice 7 years. He specializes in urologic oncology and minimally invasive surgery and is experienced in cancers of the prostate, kidney, bladder and testis.
Education & Training
Cedars-Sinai Medical CenterResidency, Urology, 2015 - 2019
George Washington University School of Medicine and Health SciencesClass of 2014
Certifications & Licensure
AZ State Medical License 2020 - 2026
CA State Medical License 2016 - 2025
CO State Medical License 2021 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Clinical Trials
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Start of enrollment: 2018 Sep 24
- Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial Start of enrollment: 2021 Mar 08
- Intravesical BCG vs GEMDOCE in NMIBC Start of enrollment: 2023 Feb 07
Publications & Presentations
PubMed
- 23 citationsPartial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Rena...Clara Cerrato, Devin Patel, Riccardo Autorino, Giuseppe Simone, Bo Yang
World Journal of Urology. 2023-03-01 - 17 citationsPreoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Co...Sunil Patel, Ithaar Derweesh, Kazutaka Saito, Dattatraya Patil, Margaret Meagher
Clinical Genitourinary Cancer. 2021-02-18 - 16 citationsRisk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the ...Zachary Hamilton, Umberto Capitanio, Deepak Pruthi, Fady Ghali, Alessandro Larcher
Urology. 2020-04-01
Press Mentions
Sicker MIBC patients no more likely to undergo bladder sparingFebruary 24th, 2020
External Links
- Google Scholarhttps://scholar.google.com/citations?user=7dijl14AAAAJ&hl=en&oi=sra
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
